Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$121.31 USD
-0.13 (-0.11%)
Updated May 10, 2024 04:00 PM ET
After-Market: $121.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 416 | 376 | 479 | 802 | 618 |
Receivables | 1,442 | 1,382 | 1,405 | 1,453 | 1,364 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,385 | 2,147 | 2,395 | 2,451 | 2,385 |
Other Current Assets | 366 | 523 | 607 | 378 | 357 |
Total Current Assets | 4,610 | 4,427 | 4,885 | 5,083 | 4,724 |
Net Property & Equipment | 2,060 | 1,873 | 2,017 | 2,048 | 2,077 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 13,675 | 13,644 | 15,492 | 16,317 | 16,857 |
Deposits & Other Assets | 1,152 | 1,122 | 1,063 | 969 | 980 |
Total Assets | 21,497 | 21,066 | 23,456 | 24,418 | 24,639 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 411 | 354 | 351 | 330 | 401 |
Current Portion Long-Term Debt | 900 | 544 | 1,605 | 500 | 1,500 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 61 | 39 | 65 | 60 | 127 |
Other Current Liabilities | 1,486 | 1,421 | 1,447 | 1,667 | 1,414 |
Total Current Liabilities | 2,857 | 2,358 | 3,468 | 2,557 | 3,442 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 358 | 475 | 666 | 790 | 840 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,868 | 5,152 | 5,464 | 7,627 | 6,721 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 926 | 1,054 | 1,193 | 1,245 | 1,243 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 9,009 | 9,039 | 10,790 | 12,218 | 12,246 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 9,846 | 9,504 | 9,315 | 9,122 | 8,920 |
Retained Earnings | 10,385 | 9,559 | 10,292 | 10,087 | 10,427 |
Other Equity | -183 | -173 | -226 | -293 | -237 |
Treasury Stock | 7,562 | 6,867 | 6,718 | 6,720 | 6,721 |
Total Shareholder's Equity | 12,488 | 12,027 | 12,666 | 12,199 | 12,393 |
Total Liabilities & Shareholder's Equity | 21,497 | 21,066 | 23,456 | 24,418 | 24,639 |
Total Common Equity | 12,488 | 12,027 | 12,666 | 12,199 | 12,393 |
Shares Outstanding | 208.98 | 209.85 | 208.90 | 207.20 | 205.60 |
Book Value Per Share | 59.76 | 57.31 | 60.63 | 58.88 | 60.28 |
Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 393 | 416 | 292 | 320 | 330 |
Receivables | 1,446 | 1,442 | 1,341 | 1,367 | 1,381 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,388 | 2,385 | 2,323 | 2,276 | 2,241 |
Other Current Assets | 404 | 366 | 416 | 425 | 460 |
Total Current Assets | 4,632 | 4,610 | 4,372 | 4,388 | 4,412 |
Net Property & Equipment | 2,091 | 2,060 | 2,032 | 1,975 | 1,906 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 13,526 | 13,675 | 13,602 | 13,771 | 13,807 |
Deposits & Other Assets | 1,204 | 1,152 | 1,211 | 1,160 | 1,119 |
Total Assets | 21,452 | 21,497 | 21,217 | 21,294 | 21,244 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 370 | 411 | 320 | 355 | 397 |
Current Portion Long-Term Debt | 970 | 900 | 355 | 520 | 585 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 234 |
Income Taxes Payable | 70 | 61 | 97 | 82 | 47 |
Other Current Liabilities | 1,386 | 1,486 | 1,300 | 1,278 | 1,073 |
Total Current Liabilities | 2,797 | 2,857 | 2,072 | 2,234 | 2,336 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 370 | 358 | 465 | 475 | 485 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,826 | 4,868 | 5,127 | 5,189 | 5,205 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 853 | 1,035 | 1,018 | 1,061 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 8,846 | 9,009 | 8,699 | 8,916 | 9,086 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 9,946 | 9,846 | 9,801 | 9,766 | 9,692 |
Retained Earnings | 10,509 | 10,385 | 10,015 | 9,902 | 9,742 |
Other Equity | -203 | -183 | -179 | -171 | -171 |
Treasury Stock | 7,649 | 7,562 | 7,122 | 7,122 | 7,109 |
Total Shareholder's Equity | 12,606 | 12,488 | 12,518 | 12,379 | 12,158 |
Total Liabilities & Shareholder's Equity | 21,452 | 21,497 | 21,217 | 21,294 | 21,244 |
Total Common Equity | 12,606 | 12,488 | 12,518 | 12,379 | 12,158 |
Shares Outstanding | 205.73 | 208.98 | 208.90 | 208.90 | 208.50 |
Book Value Per Share | 61.27 | 59.76 | 59.92 | 59.26 | 58.31 |